ABBV
AbbVie, Inc. · BIVA:ABBV
5,597.25 MXN353.19 +6.74%
AbbVie, Inc. (BIVA:ABBV) last traded at 5,597.25 MXN, up 6.74% on the day. Over the past year the stock is up 33.58%. Its 52-week range is 3,419.64 to 5,597.25. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open5,471.16
Day range5,447.99 – 5,597.25
52-week range3,419.64 – 5,597.25
Volume41
Average volume (10 days)102
Market cap (USD)521.11 B
P/E53.19
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)−0.7268
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+5.42%1 week
+17.64%1 month
+25.28%3 months
+56.92%6 months
+36.08%Year to date
+33.58%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Cantor Fitzgerald maintains AbbVie at Overweight, raises price target to $325 from $290TradingView · 02 Nov 2026
- Weekly Recap: Q3 financial gains and Skyrizi Crohn’s FDA approvalTradingView · 02 Nov 2026
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.